Related references
Note: Only part of the references are listed.Repurposed Drugs, Molecular Vaccines, Immune-Modulators, and Nanotherapeutics to Treat and Prevent COVID-19 Associated with SARS-CoV-2, a Deadly Nanovector
Taru Dube et al.
ADVANCED THERAPEUTICS (2021)
High-Dose Chloroquine for Uncomplicated Plasmodium falciparum Malaria Is Well Tolerated and Causes Similar QT Interval Prolongation as Standard-Dose Chloroquine in Children
Johan Ursing et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection
David N. Juurlink
CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)
COVID-19: don't neglect antimicrobial stewardship principles!
B. D. Huttner et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
Eli S. Rosenberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Performance of Radiologists in Differentiating COVID-19 from Non-COVID-19 Viral Pneumonia at Chest CT
Harrison X. Bai et al.
RADIOLOGY (2020)
A novel plan to deal with SARS-CoV-2 and COVID-19 disease
Raphael B. Stricker et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Mandeep R Mehra et al.
LANCET (2020)
Therapeutic Potential for Tetracyclines in the Treatment of COVID-19
Mohit Sodhi et al.
PHARMACOTHERAPY (2020)
Macrolides and viral infections: focus on azithromycin in COVID-19 pathology
Arianna Pani et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Emerging Prevention and Treatment Strategies to Control COVID-19
Vipul K. Singh et al.
PATHOGENS (2020)
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
J. M. Molina et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
COVID-19 vaccine development and a potential nanomaterial path forward
Matthew D. Shin et al.
NATURE NANOTECHNOLOGY (2020)
Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study
Xi Liu et al.
TRIALS (2020)
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
Franck Touret et al.
SCIENTIFIC REPORTS (2020)
COVID-19: an update on diagnostic and therapeutic approaches
Mahalaxmi Iyer et al.
BMB REPORTS (2020)
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement
Henning Ulrich et al.
STEM CELL REVIEWS AND REPORTS (2020)
Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention
Daniel Chandramohan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Efficacy of clarithromycin against H5N1 and H7N9 avian influenza a virus infection in cynomolgus monkeys
Masahiko Arikata et al.
ANTIVIRAL RESEARCH (2019)
Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo
Shinuan Zeng et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Variations in Antibiotic and Azithromycin Prescribing for Children by Geography and SpecialtyUnited States, 2013
Katherine E. Fleming-Dutra et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2018)
The Immunomodulatory Effects of Macrolides-A Systematic Review of the Underlying Mechanisms
Petra Zimmermann et al.
FRONTIERS IN IMMUNOLOGY (2018)
Predictive Performance of Physiologically Based Pharmacokinetic Models for the Effect of Food on Oral Drug Absorption: Current Status
Mengyao Li et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2018)
Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant The ALLOZITHRO Randomized Clinical Trial
Anne Bergeron et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial
Peter G. Gibson et al.
LANCET (2017)
Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice
Chunfeng Li et al.
EBIOMEDICINE (2017)
Azithromycin modulates immune response of human monocyte-derived dendritic cells and CD4+ T cells
Syh-Jae Lin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Azithromycin use and outcomes in severe sepsis patients with and without pneumonia
Majid Afshar et al.
JOURNAL OF CRITICAL CARE (2016)
Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients
Mandy Menzel et al.
SCIENTIFIC REPORTS (2016)
Antiviral activity of doxycycline against vesicular stomatitis virus in vitro
Zhuan-chang Wu et al.
FEMS MICROBIOLOGY LETTERS (2015)
Pharmacokinetic Interactions between Primaquine and Chloroquine
Sasithon Pukrittayakamee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
Jean-Francois Rossignol
ANTIVIRAL RESEARCH (2014)
Inhibitory effect of doxycycline against dengue virus replication in vitro
Hussin A. Rothan et al.
ARCHIVES OF VIROLOGY (2014)
The cardiovascular safety of azithromycin
David N. Juurlink
CANADIAN MEDICAL ASSOCIATION JOURNAL (2014)
Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults
Issaka Sagara et al.
MALARIA JOURNAL (2014)
Macrolides Attenuate Phorbol Ester-Induced Tumor Necrosis Factor-α and Mucin Production from Human Airway Epithelial Cells
Orapan Poachanukoon et al.
PHARMACOLOGY (2014)
Azithromycin: Mechanisms of action and their relevance for clinical applications
Michael J. Parnham et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Clinical manifestation of macrolide antibiotic toxicity in CKD and dialysis patients
Terry King-Wing Ma et al.
CLINICAL KIDNEY JOURNAL (2014)
Blood, Tissue, and Intracellular Concentrations of Azithromycin during and after End of Therapy
P. Matzneller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases
P. Zarogoulidis et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Azithromycin suppresses interleukin-12p40 expression in lipopolysaccharide and interferon-γ stimulated macrophages
Keiko Yamauchi et al.
International Journal of Biological Sciences (2012)
Macrolide Therapy in Respiratory Viral Infections
Jin-Young Min et al.
MEDIATORS OF INFLAMMATION (2012)
Interleukin-20 Antibody Is a Potential Therapeutic Agent for Experimental Arthritis
Yu-Hsiang Hsu et al.
ARTHRITIS AND RHEUMATISM (2010)
Azithromycin induces anti-viral responses in bronchial epithelial cells
V. Gielen et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Clarithromycin Inhibits Type A Seasonal Influenza Virus Infection in Human Airway Epithelial Cells
Mutsuo Yamaya et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Suppressive Effects of Azithromycin on Zymosan-Induced Production of Proinflammatory Mediators by Human Corneal Epithelial Cells
De-Quan Li et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Azithromycin alters macrophage phenotype
Brian S. Murphy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Azithromycin/Chloroquine combination does not increase cardiac instability despite an increase in monophasic action potential duration in the anesthetized guinea pig
Anthony A. Fossa et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
In vitro inhibition of human influenza A virus replication by chloroquine
Eng Eong Ooi et al.
VIROLOGY JOURNAL (2006)
Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities
C Biot et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Effect of clarithromycin on rhinovirus-16 infection in A549 cells
YJ Jang et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Anti-inflammatory effects of macrolides - an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
GW Amsden
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity
F Romanelli et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
E Keyaerts et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells
T Suzuki et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Bafilomycin A1 inhibits rhinovirus infection in human airway epithelium:: effects on endosome and ICAM-1
T Suzuki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2001)
Share Paper
